Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Jun;17(6):1023–1029. doi: 10.1128/aac.17.6.1023

Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.

D N Gerding, A J Kozak, L R Peterson, W H Hall
PMCID: PMC283922  PMID: 6996611

Abstract

Four perforated capsules were implanted into the abdominal cavity of each of three rabbits. After 4 to 5 weeks, single doses of cefazolin (30 mg/kg) or cefamandole (90 mg/kg) were administered intramuscularly. Peak levels of the respective drugs in serum were 104 +/- 10 and 127 +/- 5 micrograms/ml (mean +/- standard error); corresponding peak levels in capsule fluid were 6.3 +/- 2.3 micrograms/ml. Sixteen weeks after implantation, 2 X 10(6) colony-forming units of a strain of Escherichia coli susceptible to cefazolin (minimum inhibitory concentration, 1.0 microgram/ml) and cefamandole (minimum inhibitory concentration, less than 0.125 microgram/ml) was introduced into each of the 12 capsules. Chronic infection was established in seven of the capsules. At 4 to 6 weeks after infection, cefazolin and cefamandole were again administered. Peak serum concentrations were 102 +/- 3.3 micrograms/ml for cefazolin and 148 +/- 6.7 micrograms/ml for cefamandole. Peak concentrations in noninfected capsules were 7.5 +/- 3.4 and 12.1 +/- 2.1 micrograms/ml, respectively, not statistically different from the first study (P greater than 0.2). However, peak concentrations in infected capsules (less than 0.3 microgram/ml) were strikingly lower than in uninfected capsules (P less than 0.002). In keeping with the latter finding, quantitative cultures of E. coli in the infected capsules remained unchanged. Administration of [14C]cefamandole indicated that low drug levels were a result of poor drug penetration rather than drug inactivation or binding. Lack of vascularity and capsule wall necrosis may be responsible for poor drug penetration.

Full text

PDF
1023

Images in this article

1025Image
on p.1025
1026Image
on p.1026
1027Image
on p.1027

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Camer S. J., Tan E. G., Warren K. W., Braasch J. W. Pancreatic abscess. A critical analysis of 113 cases. Am J Surg. 1975 Apr;129(4):426–431. doi: 10.1016/0002-9610(75)90188-9. [DOI] [PubMed] [Google Scholar]
  2. Gerding D. N., Hall W. H., Schierl E. A., Manion R. E. Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits. Antimicrob Agents Chemother. 1976 Dec;10(6):902–911. doi: 10.1128/aac.10.6.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kaye D., Parsons J. N., Carrizosa J., Kobasa W. D. Treatment of experimental Staphylococcus aureus abscesses: comparison of cefazolin, cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother. 1979 Feb;15(2):200–203. doi: 10.1128/aac.15.2.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. O'Keefe J. P., Tally F. P., Barza M., Gorbach S. L. Inactivation of penicillin G during experimental infection with Bacteroides fragilis. J Infect Dis. 1978 Apr;137(4):437–442. doi: 10.1093/infdis/137.4.437. [DOI] [PubMed] [Google Scholar]
  5. O'Keefe J. P., Tally F. P., Barza M., Gorbach S. L. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis. Rev Infect Dis. 1979 Jan-Feb;1(1):106–112. doi: 10.1093/clinids/1.1.106. [DOI] [PubMed] [Google Scholar]
  6. Peterson L. R., Hall W. H., Zinneman H. H., Gerding D. N. Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics. J Infect Dis. 1977 Dec;136(6):778–783. doi: 10.1093/infdis/136.6.778. [DOI] [PubMed] [Google Scholar]
  7. Roberts E. A., NEALON T. F., Jr Subphrenic abscess: comparison between operative and antibiotic management. Ann Surg. 1974 Aug;180(2):209–212. doi: 10.1097/00000658-197408000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sabath L. D. The assay of antimicrobial compounds. Hum Pathol. 1976 May;7(3):287–295. doi: 10.1016/s0046-8177(76)80039-1. [DOI] [PubMed] [Google Scholar]
  9. Swenson R. M., Lorber B., Michaelson T. C., Spaulding E. H. The bacteriology of intra-abdominal infections. Arch Surg. 1974 Sep;109(3):398–399. doi: 10.1001/archsurg.1974.01360030050013. [DOI] [PubMed] [Google Scholar]
  10. Tally F. P., Jacobus N. V., Bartlett J. G., Gorbach S. L. Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother. 1975 Feb;7(2):128–132. doi: 10.1128/aac.7.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Washington J. A. The in vitro spectrum of the cephalosporins. Mayo Clin Proc. 1976 Apr;51(4):237–250. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES